Home » Articles » Chocamine

Chocamine Description
By David Tolson

Product Type Price
Chocamine Powder 100 grams $13.99
Displaying 1 to 1 (of 1 products) Result Pages:  1 
Introduction

Chocamine is a proprietary cocoa extract meant to provide the stimulation and health benefits of chocolate without any of the unnecessary, potentially unhealthy ingredients (such as sugar and fat). It contains numerous constituents, including methylxanthines (theobromine, caffeine, and theophylline), biogenic amines (phenylethylamine, tyramine, and according to one source, synephrine), amino acids (phenylalanine, tryptophan, tyrosine, others), minerals (with a high content of magnesium), numerous beneficial antioxidants, and possibly some non-psychoactive cannabanoid-related compounds. The combination of these multiple ingredients produces a unique effect. Promotional literature makes many positive claims about Chocamine, including increased energy, appetite suppression, increased lipolysis (fat burning), improved mood, improved concentration, increased alertness, improved physical performance, aphrodisiac properties, and health benefits. This article will examine the properties of some of the known constituents of Chocamine.

Methylxanthines

The methylxanthines are a group of compounds that include caffeine and some related stimulants. Chocamine contains methylxanthines such as theobromine, caffeine, and theophylline. Each gram of Chocamine contains 120 mg theobromine and 80 mg caffeine.

Caffeine is one of the most well-known stimulants, and functions primarily via antagonism of adenosine receptors. The properties of acute caffeine administration to humans include increased exercise performance, appetite suppression, increased rate of lipolysis, increased alertness, and reduced fatigue. Preliminary evidence suggests that regular consumption of small amounts of caffeine may also have neuroprotective and anticarcinogenic properties. On the other hand, caffeine is best avoided in those with high blood pressure and those prone to anxiety.

Theobromine is similar in both structure and function to caffeine, but it has a longer half-life, which may be one of the reasons chocamine has the reputation of being a "long-lasting stimulant." Theobromine also has a relative potency a few orders of magnitude lower than caffeine, but the amount in Chocamine (assuming a gram or more is taken) is still enough to have a psychoactive effect.

Theophylline is one of the most commonly used asthma medications due to its bronchodilating properties, and phosphodiesterase inhibition seems to play a relatively larger role in its pharmacologic activity compared to caffeine. Theophylline is also quite lipolytic, and in vitro studies indicate that it is more lipolytic than caffeine in equivalent concentrations, but it is unknown whether or not the amount in Chocamine is enough to have a significant effect.

Biogenic amines


Biogenic amines are neurotransmitter-related compounds such as synephrine, tyramine, octopamine, and phenylethylamine; these compounds are also commonly referred to as "false neurotransmitters," but the recent discovery of a specific receptor for these compounds in humans may have made this term obsolete. Nevertheless, they have many known actions in humans related to their effects on conventional receptors. Chocamine contains both phenylethylamine (PEA) and tyramine. One website indicates that it also contains synephrine, but I have been unable to confirm this as of yet.

PEA is a naturally occuring compound that behaves as a stimulant in the brain, with effects similar to those of amphetamine. However, oral bioavailability of PEA is very low, and there is not strong support for the contention that oral administration could yield a psychoactive effect, as many studies have come out negative. Some individuals may be particularly sensitive to the effects of oral PEA. Also, administration with an inhibitor of MAO-B renders PEA orally bioavailable.

Tyramine is another biogenic amine found in Chocamine. Tyramine is also found in relatively high concentrations in some foods such as aged cheese and wine. In insects, tyramine plays a similar role as a neurotransmitter to the role that epinephrine plays in mammals. In humans, tyramine can cause a release of norepinephrine. Tyramine is orally bioavailable, but unless an MAO inhibitor is being taken, large doses are required to exert an effect. It is unlikely that Chocamine contains a high enough amount of tyramine to have a significant effect, but it is possible that the tyramine content offers a mild contribution in terms of appetite suppression and lipolysis.

Synephrine is another related compound (a metabolite of tyramine), and it is an alpha(1) agonist. Synephrine has a higher oral bioavailability than most of the other trace amines. Because of its alpha(1) agonist properties, synephrine may be effective at decreasing appetite and promoting lipolysis, and it was found to be an effective therapy in an animal model of depression.

Amino acids

Chocamine contains amino acids such as phenylalanine, tyrosine, and tryptophan, all of which may have antidepressant effects, and both phenylalanine and tyrosine have stimulant effects. Although the area hasn't been explored much, research indicates that these amino acids may have additive antidepressant effects.

Tryptophan is the amino acid precursor to serotonin (5-HT), with 5-HTP as the intermediary. Many clinical studies suggest that tryptophan is an effective antidepressant, although it is not as reliably effective as 5-HTP. This is possibly due to the fact that there are more mechanisms that inhibit tryptophan transport across the blood brain barrier and conversion to serotonin. On top of this, it is unlikely that the amounts present in Chocamine are large enough to cause a significant change in brain serotonin status. Either way, the presence of this amino acid can be considered a possible benefit, but for a more reliable serotonergic antidepressant, 5-HTP is recommended. Tryptophan is yet another compound in chocamine that may contribute to appetite suppression.

Tyrosine is the precursor to the neurotransmitter dopamine (DA). In humans, tyrosine supplementation leads to increased dopamine and norepinephrine levels in the brain without competitive inhibition of other amino acids. In turn, this may lead to the antidepressant, stimulant, and appetite suppressant effects of tyrosine observed in some studies.

Phenylalanine is the precursor to PEA. It is also a precursor to tyrosine, and is active in smaller doses. Unlike PEA itself, oral supplementation with phenylalanine may increase levels of PEA in the brain, although the literature is contradictory on this point. One trial indicated that L-phenylalanine had an antidepressant effect, but it was an open trial. As is the case with PEA, L-phenylalanine is also an effective antidepressant when coadministered with an MAO-B inhibitor.

Minerals

Chocamine is reported to be rich in both magnesium and copper. There is generally no need for extra copper, although zinc, chromium, and vitamin C can all inhibit copper absorption to an extent. However, extra magnesium is generally beneficial. Increased magnesium intake has been associated with decreased risk of various cardiovascular disease states, and is also beneficial for the treatment of some conditions (such as migraine headaches). Other minerals found in chocolate, and presumably also present in Chocamine, are calcium and potassium.

Phytonutrients

Cocoa contains both plant sterols and fiber, both of which are beneficial to cardiovascular health, but the sterol content is low (and probably even lower when the fat is removed), and the fiber is lost with processing. However, cocoa contains high quantities of flavanoids (a class of polyphenols), including proanthocyanidins and the flavan-3-ols catechen and epicatechin, and according to the promotional literature, Chocamine is high in these compounds (and this is undoubtedly the case, since they are quite easy to extract). The content and makeup of these phytonutrients in chocolate is similar to that in apples (it is higher on a per weight basis, but less on a per calorie basis). Chocolate has been found to increase the content of these flavan-3-ols and proanthocyanidins in the bloodstream in humans. Other studies indicate that the antioxidant capacity of chocolate is comparable with that of garlic, blueberries, and strawberries. In three studies, ingestion of cocoa products was found to decrease LDL oxidation. Although well-designed epidemiological studies have not been done, studies have found cardiovascular disease reduction from other foods high in these compounds. It has also been suggested that chocolate/cocoa may share the anti-carcinogenic properties of foods with similar phytonutrients.

Conclusions

Chocamine contains many beneficial ingredients, especially if one is looking for CNS stimulation and appetite suppression. The effects could be compared to those of amphetamine, but not as potent or euphoric. Although it is likely that only 5 or 6 of the compounds in Chocamine are found in sufficient quantity to exert an effect, the combination of the many ingredients together will offer many subtleties and make for a rather unique supplement. This is a supplement that should be definitely avoided by those prone to anxiety attacks or with cardiovascular conditions because of the stimulating effects. Like other stimulants, it shouldn't be used before bed, and caution is strongly advised when combining with other stimulants. Recommended dosage is 1 gram 1-3 times daily (if in doubt, start low and move up). Although Chocamine undoubtedly is quite effective on it's own, the following supplements may have additive benefits when used at the same time.
  • 5-HTP also has antidepressant and appetite suppressant properties, but through a different pathway. Chocamine may also help counteract the drowsiness/fatigue that some report from 5-HTP.
  • Green tea extract can be used to increase the flavanoid content, provide further health benefits, and increase fat burning. Green tea extract is one of the least expensive and most potent sources of phytonutrients.
  • D,L-phenylalanine and/or L-tyrosine can both be used to increase the content of these amino acids – both will provide a further antidepressant and appetite suppressant effect. The D form of phenylalanine, not found in Chocamine, will also have some unique benefits (see the DL-phenylalanine article).
  • Yohimbine is lipolytic, and an appetite suppressant, and will add on to the reputed sexual stimulant effects of Chocamine. It is also synergistic with methylxanthines for fat loss. However, a high degree of caution is advised when stacking these (start low to monitor your reaction), and it is also likely to cause significant anxiety in those who are prone to it.

If you have any questions or comments regarding this article, please email dvdtlsn@bulknutrition.com.


No part of this article may be reproduced in any form without the permission of David Tolson or Mike McCandless.

Recent Related Forum Topics
TopicTopic StarterStart Date
Chocamine and anxietycovacorna08/07/04 - 10:39 AM

 Show All  Topics Post New  Topic 


References
Acta Pharmacol Toxicol (Copenh). 1984 Jan;54(1):64-71. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. Fredholm BB, Lindgren E.

Altern Med Rev. 2000 Feb;5(1):64-71. Use of neurotransmitter precursors for treatment of depression. Meyers S.

Am J Clin Nutr. 2003 Jun;77(6):1442-7. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Jessen AB, Toubro S, Astrup A.

Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R399-404. Epub 2002 Oct 24. Central nervous system effects of caffeine and adenosine on fatigue. Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA.

Ann Neurol. 2001 Jul;50(1):56-63. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC.

Arch Insect Biochem Physiol. 2003 Sep;54(1):1-13. Tyramine and octopamine: antagonistic modulators of behavior and metabolism. Roeder T, Seifert M, Kahler C, Gewecke M.

Brain Res. 1976 Sep 10;114(1):105-15. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Silkaitis RP, Mosnaim AD.

Br J Clin Pharmacol. 1986 Aug;22(2):177-82. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Lelo A, Birkett DJ, Robson RA, Miners JO.

Br J Nutr. 2001 Feb;85(2):203-11. Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Yoshioka M, Doucet E, Drapeau V, Dionne I, Tremblay A.

Br J Pharmacol. 1988 Feb;93(2):417-29. Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Brown CM, McGrath JC, Midgley JM, Muir AG, O'Brien JW, Thonoor CM, Williams CM, Wilson VG.

Cancer Lett. 2003 May 8;194(1):25-35. Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Takeshita F, Ogawa K, Asamoto M, Shirai T.

Clin Chim Acta. 2000 Apr;294(1-2):1-26. Magnesium. An update on physiological, clinical and analytical aspects. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A.

Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):391-4. Effects of caffeine on the uncoupling protein family in obese yellow KK mice. Kogure A, Sakane N, Takakura Y, Umekawa T, Yoshioka K, Nishino H, Yamamoto T, Kawada T, Yoshikawa T, Yoshida T.

Eur J Neurol. 2002 Jul;9(4):377-82. Does caffeine intake protect from Alzheimer's disease? Maia L, de Mendonca A.

Exp Biol Med (Maywood). 2001 Nov;226(10):891-7. Chemopreventive effects of cocoa polyphenols on chronic diseases. Weisburger JH.

J Am Diet Assoc. 2003 Feb;103(2):215-23. Cocoa and chocolate flavonoids: implications for cardiovascular health. Steinberg FM, Bearden MM, Keen CL.

J Appl Physiol. 2002 Oct;93(4):1227-34. Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. Bell DG, McLellan TM.

J Clin Endocrinol Metab 1983 Oct;57(4):760-3. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations. Rasmussen DD, Ishizuka B, Quigley ME, Yen SS.

J Clin Pharmacol. 2003 Jun;43(6):604-9. Tyramine pharmacokinetics and reduced bioavailability with food. VanDenBerg CM, Blob LF, Kemper EM, Azzaro AJ.

J Exp Clin Cancer Res. 2001 Jun;20(2):287-92. Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. Gude RP, Menon LG, Rao SG.

J Lipid Res. 1993 Oct;34(10):1737-43. Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis. Arner P, Hellmer J, Hagstrom-Toft E, Bolinder J.

J Neural Transm 1980;47(4):299-306. Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals. Melamed E, Glaeser B, Growdon JH, Wurtman RJ.

J Neural Transm. 1984;59(1):81-7. L-deprenyl plus L-phenylalanine in the treatment of depression. Birkmayer W, Riederer P, Linauer W, Knoll J.

J Neurol Neurosurg Psychiatry. 1977 Feb;40(2):179-85. Effects of oral amines on the EEG. Scott DF, Moffett AM, Swash M.

J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):168-71. Sustained antidepressant effect of PEA replacement. Sabelli H, Fink P, Fawcett J, Tom C.

J Pharmacol Exp Ther 1990 Nov;255(2):403-9. L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats. Hull KM, Maher TJ.

Neurosci Lett. 1996 Aug 23;214(2-3):107-10. Antidepressant-like effects of p-synephrine in mouse models of immobility tests. Song DK, Suh HW, Jung JS, Wie MB, Son KH, Kim YH.

Psychopharmacology (Berl). 1994 Jun;115(1-2):1-8. Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR.

Nutr Neurosci. 2003 Aug;6(4):237-46. Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR, Lieberman HR, McNevin N, Ryan DH.

Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(5):611-23. Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers. Davis BA, O'Reilly RL, Placatka CL, Paterson IA, Yu PH, Durden DA.

Welcome Guest Log In
 
 
 
 My AccountShopping CartCheckout 
 Go Endurance Supplement ReviewsGo Endurance ArticlesGo Endurance Forums and Message Boards 
 
 


New Articles
- Gastric Bypass Diet
- Theanine Science
- Brain Food: Aniracetam
- Saw Palmetto
- Citrulline Malate

What's New?
Stamina-Rx Sex on the Beach
Stamina-Rx Sex on the Beach
$21.95

Specials
Whey Protein
Whey Protein
$72.99
$69.99

Protected Checkout


Copyright © 2002-2008 GoEndurance.com
Powered by MirageCommerce

Best Nutritional Supplement Stores for Health, Fitness, Bodybuilding and Sports Enthusiasts
ExpertFitness.com also recommends:
Wholesale Nutrition Store - Brand Name Nutrition at Wholesale Prices   MuscleSuff.com - Cheap Nutritional Supplements for Diet and Bodybuiling   Nutritional supplements at Beyond Muscle for athletics and active lifestyle


Bulk Nutrition | 1Fast400 Nutrition | Beyond Muscle | Nutrition Stand | Go Endurance